
Description Medifocus Inc. engages in the development and commercialization of minimally invasive and focused heat tumor targeting cancer treatment devices and systems. It owns a patented microwave focusing technology platform, the Adaptive Phased Array thermotherapy system, which would precisely target and concentrate microwave energy to destroy cancer tumors without damaging healthy tissues when used alone or in conjunction with chemotherapy or radiation. The company is conducting Phase III clinical trials of its proprietary breast cancer treatment (APA 1000) system. Medifocus Inc. is based in Toronto, Canada. To view the detailed information, you need to SUBSCRIBE with us. |
![]() |